L-glutamine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on glycated haemoglobin (HbA1c)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“Fasting glycemia and glycated hemoglobin A1c values before and after 60 days of supplementation with EGln or maltodextrin indicated prediabetes, but no significant differences were observed between the EGln and placebo groups.”
Quoted verbatim from Tolerability of glutamine supplementation in older adults: a double-blind placebo-controlled randomized clinical trial.. - Study
- RCT
- Participants
- 30
- Duration
- 2 months
- Dose
- 12.4 g oral effervescent glutamine daily
- Population
- community-dwelling older adults aged over 60 from three daycare centres in Brazil; safety/tolerability endpoint, not the trial's primary outcome
Tolerability of glutamine supplementation in older adults: a double-blind placebo-controlled randomized clinical trial.2024PMID:38808890Permalink
Keep reading
- Everything the graph holds on L-glutamine
- Every compound studied against Glycated haemoglobin (HbA1c)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M0Y3JJ8DKZPEX74D2S2YVF44